Mo1295 PROXIMAL ESOPHAGEAL IMPEDANCE BASELINE INCREASES THE YIELD OF IMPEDANCE-PH AND IS ASSOCIATED WITH RESPONSE TO PPIS IN CHRONIC COUGH PATIENTS
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Mentore Ribolsi, Nicola De Bortoli, Marzio Frazzoni, Lorenzo Marchetti, Edoardo Savarino, Michele Cicala Tags: AGA Abstracts Source Type: research

Mo1293 PH IMPEDANCE MONITORING ON PROTON PUMP INHIBITOR THERAPY IN UNPROVEN GERD DOES NOT IMPACT DECISIONS REGARDING FURTHER ACID SUPPRESSION BUT CAN IDENTIFY REFRACTORY GERD IN PROVEN GERD PATIENTS
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Benjamin D. Rogers, Rena Yadlapati, Sabine Roman, Dustin Carlson, John E. Pandolfino, C. Prakash Gyawali Tags: AGA Abstracts Source Type: research

Mo1278 ANXIETY IS DIFFERENTLY ASSOCIATED WITH GERD PHENOTYPES AND PREDICTS PPIS REFRACTORINESS IN GERD PATIENTS
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Mentore Ribolsi, Lorenzo Marchetti, Lucrezia Maria Olmi, Michele Cicala Tags: AGA Abstracts Source Type: research

Mo1275 UTILITY OF AMBULATORY PH MONITORING ON PROTON PUMP INHIBITOR THERAPY IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX PULMONARY INFECTION
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Mayank Nihalani, Wendelyn Bosch, Margaret Johnson, Andree Koop Tags: AGA Abstracts Source Type: research

Mo1180 INTERACTIONS OF PROTON PUMP INHIBITOR THERAPY WITH TICAGRELOR AND ASSESSMENT OF CARDIOVASCULAR OUTCOMES IN PATIENTS TREATED FOR ACUTE CORONARY SYNDROME
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Clive J. Miranda, Thomas J. Drago, Timothy J. Avino, Leonard Palatnic, Andrew Monte, Ali Aijaz, Sourabh Goyal, Kristopher Attwood, Mohamad I. Itani, Farhan Azad, Weam M. Altaher, Srekar N. Ravi, Naren S. Nallapeta Tags: AGA Abstracts Source Type: research

147 open-capsule proton pump inhibitor is associated with fewer complications of marginal ulceration after roux-eny gastric bypass
(Source: Gastroenterology)
Source: Gastroenterology - May 6, 2024 Category: Gastroenterology Authors: Heesoo Yoo, Alvin Kwon, Alison Zhao, Varun Aitharaju, Kristelle J. Imperio-Lagabon, Stephen A. Firkins, Roma Patel, Bailey Flora, Roberto Simons-Linares Tags: SSAT Abstracts Source Type: research

Integrated Models of Population Pharmacokinetics and Exposure Response to Optimize Dosage Regimen for Anaprazole Sodium in Duodenal Ulcer
In conclusion, the drug is safe when dosing between 20 and 100 mg once a day.PMID:38703917 | DOI:10.1016/j.ejps.2024.106781 (Source: European Journal of Pharmaceutical Sciences)
Source: European Journal of Pharmaceutical Sciences - May 4, 2024 Category: Drugs & Pharmacology Authors: Lei Zhang Ling Song Cheng Cui Chunyang Wang Yi Zhang Xueting Yao Dongyang Liu Source Type: research

Integrated models of population pharmacokinetics and exposure response to optimize dosage regimen for anaprazole sodium in duodenal ulcer
In conclusion, the drug is safe when dosing between 20 and 100 mg once a day.PMID:38703917 | DOI:10.1016/j.ejps.2024.106781 (Source: European Journal of Pharmaceutical Sciences)
Source: European Journal of Pharmaceutical Sciences - May 4, 2024 Category: Drugs & Pharmacology Authors: Lei Zhang Ling Song Cheng Cui Chunyang Wang Yi Zhang Xueting Yao Dongyang Liu Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology : WJG - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology : WJG - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology : WJG - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy
World J Gastroenterol. 2024 Apr 28;30(16):2220-2232. doi: 10.3748/wjg.v30.i16.2220.ABSTRACTSeveral features of drug-induced mucosal alterations have been observed in the upper gastrointestinal tract, i.e., the esophagus, stomach, and duodenum. These include pill-induced esophagitis, desquamative esophagitis, worsening of gastroesophageal reflux, chemotherapy-induced esophagitis, proton pump inhibitor-induced gastric mucosal changes, medication-induced gastric erosions and ulcers, pseudomelanosis of the stomach, olmesartan-related gastric mucosal inflammation, lanthanum deposition in the stomach, zinc acetate hydrate tablet...
Source: World Journal of Gastroenterology - May 1, 2024 Category: Gastroenterology Authors: Masaya Iwamuro Seiji Kawano Motoyuki Otsuka Source Type: research